Análisis Argos
MRVL
MRVLCara1 señal de riesgo
Marvell Technology, Inc. · Technology
US$ 174.47
precio al 2026-07-28
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
48/100
LA RESPUESTA
El mercado le pide crezca 60% al año — más de lo que ha demostrado (7.5%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
!Beneish M-Score sugiere manipulación (-1.59)
VALOR1/6FUTURO5/6PASADO4/6SALUD3/6DIVIDENDO2/6
El Iris de calidad
VALOR1/6FUTURO5/6PASADO4/6SALUD3/6DIVIDENDO2/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos48de 100Cara
Ingresos42%
US$ 8.2 B
Margen operativo230%
16.3%
Flujo de caja libre1%
US$ 1.4 B
Deuda neta
US$ 2.2 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 152.8B
P/E57.2x
EV/EBITDA58.9x
FCF yield0.9%
ROIC7.1%
Margen operativo16.3%
Crecim. ingresos+42.1%/año
Piotroski F8/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

247wallst.com · 19 jul
Wall Street Is Warming to Marvell After Its XConn Acquisition. Here's The Price Target
Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction) has been one of the most volatile large-cap AI infrastructure stocks of 2026.
247wallst.com · 19 jul
The AI ‘Memory Wall' Is About to Get a Lot Taller: These 3 Stocks Will Win Big
Artificial intelligence has been defined by a relentless race for more computing power.
seekingalpha.com · 19 jul
Our Top 10 High Growth Dividend Stocks - July 2026
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 500 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum and is suitable for investors in the accumulation phase.
zacks.com · 17 jul
The Tech Shakeout: Market Extremes & Gavin Baker's Bold Call
Tech and momentum stocks are seeing some of the highest volatility recorded in decades.
fool.com · 17 jul
2 Stocks to Buy in the Chip Stock Sell-Off
Don't let the volatility scare you away.
247wallst.com · 17 jul
3 Semiconductor Stocks to Buy Before AI Demand Explodes in July
AI infrastructure spending has become a supply-constrained reality.
zacks.com · 16 jul
Marvell Technology (MRVL) Falls More Steeply Than Broader Market: What Investors Need to Know
Marvell Technology (MRVL) reached $188.3 at the closing of the latest trading day, reflecting a -8.71% change compared to its last close.
newsfilecorp.com · 16 jul
Marvel Biosciences Announces Private Placement for up to $3.0 Million
Calgary, Alberta--(Newsfile Corp. - July 16, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") is pleased to announce that it intends to complete a non‐brokered private placement offering (the "Offering") of units of the Company ("Units") at a price of $0.15 per Unit. The Offering will be for a minimum of 10,000,000 Units for gross proceeds of $1,500,000, and up a maximum of 20,000,000 Units, for gross proceeds of up to $3,000,000.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.